X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (423) 423
Publication (41) 41
Patent (27) 27
Book Chapter (13) 13
Conference Proceeding (8) 8
Book / eBook (7) 7
Book Review (6) 6
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (123) 123
male (108) 108
index medicus (99) 99
humans (98) 98
cannabinoids (93) 93
neurosciences (73) 73
female (63) 63
rats (63) 63
basal ganglia (51) 51
endocannabinoids (47) 47
receptors (45) 45
pharmacology & pharmacy (43) 43
mice (42) 42
neuroprotection (42) 42
middle aged (34) 34
neurodegeneration (33) 33
aged (31) 31
brain (30) 30
cannabinoid (30) 30
parkinson's disease (30) 30
analysis (29) 29
cb1 receptors (29) 29
disease models, animal (29) 29
cannabinoid receptors (28) 28
cannabinoids - pharmacology (28) 28
endocannabinoid system (28) 28
tetrahydrocannabinol (27) 27
receptor, cannabinoid, cb1 - metabolism (26) 26
acid amide hydrolase (25) 25
huntington's disease (25) 25
neurons (25) 25
anandamide (24) 24
brain - metabolism (24) 24
dopamine - metabolism (24) 24
rats, sprague-dawley (24) 24
rats, wistar (23) 23
chemistry (22) 22
neurology (22) 22
receptor, cannabinoid, cb2 - metabolism (22) 22
cb2 receptors (21) 21
lipids (21) 21
receptor (21) 21
receptors, cannabinoid (21) 21
cannabinoids - metabolism (20) 20
chemistry, medicinal (20) 20
metallurgy (20) 20
research (19) 19
brain - drug effects (18) 18
health aspects (18) 18
human necessities (18) 18
hygiene (18) 18
medical or veterinary science (18) 18
preparations for medical, dental, or toilet purposes (18) 18
arachidonic acids - pharmacology (17) 17
biochemistry & molecular biology (17) 17
cannabinoids - therapeutic use (17) 17
cb1 receptor (17) 17
nervous system (17) 17
pyrazoles - pharmacology (17) 17
receptors, drug - metabolism (17) 17
spain (17) 17
adult (16) 16
amyotrophic lateral sclerosis (16) 16
dopamine (16) 16
dose-response relationship, drug (16) 16
gaba (16) 16
huntingtons-disease (16) 16
messenger-rna levels (16) 16
motor activity - drug effects (16) 16
polyunsaturated alkamides (16) 16
cannabinoid receptor (15) 15
cannabinoid receptor modulators (15) 15
parkinsons-disease (15) 15
pharmacology (15) 15
activation (14) 14
cannabidiol (14) 14
enzymes (14) 14
epidemiology (14) 14
infectious diseases (14) 14
inflammation (14) 14
medicine (14) 14
multidisciplinary sciences (14) 14
organic chemistry (14) 14
brain chemistry - drug effects (13) 13
cannabinoid receptor modulators - metabolism (13) 13
cb1 and cb2 receptors (13) 13
central-nervous-system (13) 13
huntington disease - drug therapy (13) 13
in-vivo (13) 13
microbiology (13) 13
multiple sclerosis (13) 13
neuroprotective agents - pharmacology (13) 13
receptor, cannabinoid, cb1 - genetics (13) 13
aged, 80 and over (12) 12
biomedicine (12) 12
cell biology (12) 12
clinical neurology (12) 12
delta-tetrahydrocannabinol (12) 12
disease progression (12) 12
expression (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Pharmacology, ISSN 0007-1188, 05/2019, Volume 176, Issue 10, pp. 1370 - 1383
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 04/2009, Volume 156, Issue 7, pp. 1029 - 1040
There is evidence that cannabinoid-based medicines that are selective for different targets in the cannabinoid signalling system (e.g. receptors, inactivation... 
basal ganglia | neuroprotection | basal ganglia disorders | cannabinoids | cannabinoid receptors | movement | symptom relief | Neuroprotection | Basal ganglia | Cannabinoids | Movement | Symptom relief | Basal ganglia disorders | Cannabinoid receptors | TOXICITY IN-VIVO | HUNTINGTONS-DISEASE MICE | RECEPTOR MESSENGER-RNA | GTP-BINDING PROTEINS | RAT STRIATAL NEURONS | LEVODOPA-INDUCED DYSKINESIA | NIGROSTRIATAL DOPAMINERGIC-NEURONS | ACID AMIDE HYDROLASE | CANNABINOID CB1 RECEPTORS | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | Receptor, Cannabinoid, CB2 - agonists | Signal Transduction | Humans | TRPV Cation Channels - agonists | Basal Ganglia - metabolism | Parkinson Disease - drug therapy | Basal Ganglia Diseases - drug therapy | Parkinson Disease - physiopathology | Huntington Disease - metabolism | Cannabinoid Receptor Modulators - physiology | Cannabinoids - therapeutic use | Movement Disorders - metabolism | Movement Disorders - physiopathology | Receptor, Cannabinoid, CB1 - agonists | Basal Ganglia Diseases - physiopathology | Basal Ganglia Diseases - metabolism | Parkinson Disease - metabolism | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Huntington Disease - drug therapy | Endocannabinoids | Huntington Disease - physiopathology | Movement Disorders - drug therapy | Index Medicus | Review
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 05/2019, Volume 176, Issue 10, pp. 1370 - 1383
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 11/2018, Volume 157, pp. 1 - 7
Journal Article
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 07/2016, Volume 173, Issue 13, pp. 2069 - 2079
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2009, Volume 4, Issue 6, pp. e5777 - e5777
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 7, pp. 1 - 11
Background: The transcription factor Nrf2 (NF-E2-related factor 2) and its target gene products, including heme oxygenase-1 (HO-1), elicit an antioxidant... 
COMPLEX I | OXIDATIVE STRESS | TRANSCRIPTION FACTOR NRF2 | CARBON-MONOXIDE | MULTIDISCIPLINARY SCIENCES | THERAPEUTIC TARGET | IRON | DOPAMINERGIC-NEURONS | ALPHA-SYNUCLEIN | SUBSTANTIA-NIGRA | NEURODEGENERATIVE DISEASES | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology | Immunohistochemistry | NF-E2-Related Factor 2 - physiology | Gliosis - genetics | Heme Oxygenase-1 - metabolism | Mice, Inbred C57BL | Gliosis - chemically induced | Immunoblotting | Chromatography, High Pressure Liquid | Parkinson Disease - genetics | Iron - metabolism | Mice, Knockout | Neurotoxins - pharmacology | Heme Oxygenase-1 - genetics | Animals | Fluorescent Antibody Technique | Polymerase Chain Reaction | NF-E2-Related Factor 2 - genetics | Mice | Parkinson Disease - metabolism | Dopamine - metabolism | Proteins | Tyrosine | Antioxidants | Parkinson's disease | Neurons | Genes | Heme | Genetic transcription | Health aspects | Therapy | Oxidative stress | Biotechnology | Neuroprotection | Transcription factors | Basal ganglia | Substantia nigra | Parkinsons disease | Staining | Iron | Biochemistry | Neurotoxicity | Neurodegeneration | Rodents | Neostriatum | Dihydroxyphenylacetic acid | Degeneration | NRF2 protein | Deposition | Neurological disorders | Movement disorders | Dopamine receptors | Dopamine | Neurodegenerative diseases | Hydroxylase | Heme oxygenase (decyclizing) | Central nervous system diseases | Perl | Pharmacology | Liquid chromatography | Biophysics | Metabolism | Gene expression | High-performance liquid chromatography | Monkeys & apes | Ganglia | Oxygenase | Gliosis | Sensitivity enhancement | MPTP
Journal Article
Journal Article